Healthcare & Medical Devices Global On demand · 24-48h

Global Flash Continuous Glucose Monitor Market Strategic Research Report

Global Flash Continuous Glucose Monitor Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Flash Continuous Glucose Monitor Market
$9.69B2025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Electrochemical Enzyme Sensor Type, Microneedle Sensor Type, Flexible Electronic Sensor Type

By Application: Hospital, Home-Based Management, Exercise and Health, Insulin Therapy Support and Management, Telemedicine

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Abbott, Dexcom Inc, Ascensia Diabetes Care, Terumo Corporation, Medtronic Diabetes, Roche Diabetes Care, Cnoga Medical, i-SENS, Sinocare Inc, MicroTech Medical, Meiqi Medical, Novo Nordisk Digital Health, SIBIONICS

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 111 pages
Market size 2025
$9.69B
Billion USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$14.2B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Flash Continuous Glucose Monitor market size is predicted to grow from US$ 9,685 million in 2025 to US$ 14,166 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

In 2025, global Flash Continuous Glucose Monitorproduction reached approximately 180 million units, and the average price was US$55 per unit.The Flash Continuous Glucose Monitor is a device based on minimally invasive sensing technology. It continuously measures interstitial glucose levels via a subcutaneous sensor and stores the data internally; users obtain current readings, historical trends, and glucose profiles by scanning the sensor. The system typically comprises a disposable sensor, a reader or smartphone app, a data management platform, and supporting software. Compared to traditional finger-prick testing, FGM eliminates the need for frequent blood sampling and provides continuous glucose data. Compared to real-time CGM, its key characteristics include user-initiated scanning for data retrieval, a simpler device structure, a longer wear duration, and lower costs. These products are primarily used for patients with Type 1 diabetes, insulin-dependent Type 2 diabetes, and scenarios requiring precise glycemic control, serving as a vital component of digital diabetes management systems.

Driven by the rising global prevalence of diabetes, evolving approaches to glycemic management, the adoption of home-based care, and advancements in wearable medical devices, FGM technology is transitioning from a traditional testing tool into a device for long-term health management. Key opportunities lie in the widespread adoption of low-cost CGM, smartphone integration, diabetes management at the primary care level, connectivity with telehealth platforms, glucose monitoring for pediatric and elderly patients, and integration with insulin pumps and digital therapeutics. Core industry competitiveness hinges on sensor accuracy, wearer comfort, sensor stability, operational lifespan, data algorithm capabilities, device miniaturization, and the ability to build an ecosystem platform. Current industry challenges include high sensor prices, the financial burden of long-term use for some patients, the lack of continuous active alerts in the scanning-based mode, skin irritation issues, insufficient data compatibility across devices, and limited depth in the application of medical data. Solutions involve improving sensor manufacturing processes, reducing production costs, developing longer-lasting sensors, enhancing AI-driven glucose prediction algorithms, optimizing mobile data interaction, and fostering integration with hospital information systems and chronic disease management platforms. Overall, the industry is evolving toward higher accuracy, lower costs, extended operational life, greater intelligence, and enhanced connectivity, increasingly establishing itself as a crucial digital medical tool for long-term diabetes management.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Flash Continuous Glucose Monitor market?

What factors are driving Flash Continuous Glucose Monitor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Flash Continuous Glucose Monitor market opportunities vary by end market size?

How does Flash Continuous Glucose Monitor break out by Type, by Application?

This report presents a comprehensive overview of the global Flash Continuous Glucose Monitor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Electrochemical Enzyme Sensor Type
  • Microneedle Sensor Type
  • Flexible Electronic Sensor Type

Segment by Cycle

  • Short Cycle (≤7 Days)
  • Standard Cycle (8–14 Days)
  • Long Cycle (15–30 Days)

Segment by Application

  • Hospital
  • Home-Based Management
  • Exercise and Health
  • Insulin Therapy Support and Management
  • Telemedicine

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Flash Continuous Glucose Monitor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Home-Based Management, Exercise and Health evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Flash Continuous Glucose Monitor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$9.69B
2025
Forecast
$14.2B
2032
CAGR
5.6%
2025–2032
영역들
5
global
Key companies
AbbottDexcom IncAscensia Diabetes CareTerumo CorporationMedtronic DiabetesRoche Diabetes CareCnoga Medicali-SENS
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Electrochemical Enzyme Sensor TypeMicroneedle Sensor TypeFlexible Electronic Sensor Type
By Application
HospitalHome-Based ManagementExercise and HealthInsulin Therapy Support and ManagementTelemedicine

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Electrochemical Enzyme Sensor Type
  • 3.1.3 Microneedle Sensor Type
  • 3.1.4 Flexible Electronic Sensor Type
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Home-Based Management
  • 4.1.4 Exercise and Health
  • 4.1.5 Insulin Therapy Support and Management
  • 4.1.6 Telemedicine
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Abbott
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Dexcom Inc
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Ascensia Diabetes Care
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Terumo Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Medtronic Diabetes
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Roche Diabetes Care
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cnoga Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 i-SENS
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sinocare Inc
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 MicroTech Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Meiqi Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Novo Nordisk Digital Health
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 SIBIONICS
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Flash Continuous Glucose Monitor market?
The global Flash Continuous Glucose Monitor market is estimated at US$ 9.69 billion in 2025 (base year) and is projected to reach US$ 14.17 billion by 2032.
How fast is the Flash Continuous Glucose Monitor market expected to grow?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 9.69 billion in 2025 to US$ 14.17 billion in 2032, roughly 1.5 times its base-year value.
What does the Flash Continuous Glucose Monitor market cover?
In 2025, global Flash Continuous Glucose Monitorproduction reached approximately 180 million units, and the average price was US$55 per unit.The Flash Continuous Glucose Monitor is a device based on minimally invasive sensing technology. It continuously measures interstitial glucose levels via a subcutaneous sensor and stores the data internally; users obtain current readings, historical trends, and glucose profiles by scanning the sensor.
What are the main segments of the Flash Continuous Glucose Monitor market by type?
By type, the market is segmented into Electrochemical Enzyme Sensor Type, Microneedle Sensor Type and Flexible Electronic Sensor Type.
Which applications drive demand in the Flash Continuous Glucose Monitor market?
Key applications covered include Hospital, Home-Based Management, Exercise and Health, Insulin Therapy Support and Management and Telemedicine.
Who are the key players in the Flash Continuous Glucose Monitor market?
Key players profiled include Abbott, Dexcom Inc, Ascensia Diabetes Care, Terumo Corporation, Medtronic Diabetes, Roche Diabetes Care, Cnoga Medical and i-SENS, among 13 companies covered in total.
Which regions and countries are covered for Flash Continuous Glucose Monitor?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Flash Continuous Glucose Monitor market?
Driven by the rising global prevalence of diabetes, evolving approaches to glycemic management, the adoption of home-based care, and advancements in wearable medical devices, FGM technology is transitioning from a traditional testing tool into a device for long-term health management.
What challenges does the Flash Continuous Glucose Monitor market face?
Current industry challenges include high sensor prices, the financial burden of long-term use for some patients, the lack of continuous active alerts in the scanning-based mode, skin irritation issues, insufficient data compatibility across devices, and limited depth in the application of medical data.
Who should buy the Flash Continuous Glucose Monitor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Home-Based Management and Exercise and Health, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Flash Continuous Glucose Monitor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.